AGED Diagnostics

San Francisco, United States · Founded 2022

Employees
1–10
Founded
2022
Business Model
B2B
Last Round
Pre-SeedAug 2025
Rounds
1

About

AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for the early detection and staging of liver disease. Its genomics-based assays detect circulating genetic signatures associated with conditions such as fibrosis and steatohepatitis (NASH) and liver cancer, aiming to give clinicians an earlier, more affordable alternative to biopsy and current screening methods so patients can access intervention sooner.

Summary

AGED Diagnostics is a Medtech company based in San Francisco, United States, founded in 2022. Its most recent funding was a Pre-Seed round in Aug 2025. Investors include TEDCO, Plug and Play and Central Texas Angel Network.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedAug 2025

Investors

Similar Companies